Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reminder :
DISCUSSING OTHER STOCKS, SPAMMING, AND/OR PERSONAL ATTACKS WILL NOT BE TOLERATED!!
We are being watched here.
Totally agree with you.
You think the uptrend will only begin Q2 even Q3? Would be awesome to have a late breaking abstract for ASCO with Merck :) But I'm dreaming.
Sometimes, I almost feel that cancelling the S-3, would be a catalyst for us. Would also be nice to have some institutional investors with us.
I'm not a TA guy, but considering November 24 a bottom when it passed 0.49 just a month before.
And I don't think MM are taking stop loss neither, doesn't move that fast. I remember freaking out last April, 0.80s to 0.45 and back up. Today is just slow, people want cash upfront.
Quite depressing,
Wish Punit would have one last surprise during conference call, but I start to think we'd need cash support from Merck or sth, to move that PPS back to 0.80s .. eventually over a 1$
Getting to your great barrier, 50 cents..
Let's see if that hold
Indeed... at least we have nothing to worry ;) $ONCS is still on the right path. It was all good results, but stuff everybody expected I guess. Maybe people expected more details about Phase IIB, especially up front cash. But I'm no expert on the subject.
It is really good news but it just confirms what we already knew from ASCO. For anyone really deeply invested in $ONCS (like me and many other), we don't have to worry for a while and $$ will eventually come. I think there will be more & more interests into $ONCS in 1H2015 as we approach first data from Phase IIB.
Hey Tom123, would be a good time for a pullback analysis.
Might have a small rally later on, don't we have more results tomorrow, same time ?
We can expect another PR around the same time tomorrow, as we are also selected among the bests abstracts !
T-1h
We can only remove our own stickies, sorry
Melanoma Bridge 2014 happening right now
December 4th 2014
Combination Therapies
18:05 (that's 12:05EST) Discussion on the best abstracts submitted on Combination Therapies Paolo A. Ascierto, Giuseppe Palmieri
Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma (Adil Daud, Kathryn Toshimi Takamura, Tu Diep, Richard Heller, Robert H. Pierce)
http://www.melanomabridge.org
Thought I read something like their aim was to eventually break down Il-12 and see if they cannot take just a part of it for their treatment and eventually produce a patented drug or something.
Then this collaboration will accelerate their research, no?
I might be saying complete b*llcr*p cause I don't know if you can actually break down IL-12 ? Again, though I read that during spring.
I meant 2 x $Bs Market Caps pharmas.
How long until we join the club ;) ?
Good stuff, $ONCS collaborating with 2 $B Market Cap Pharmas now.
Short Volume of the day. 49%
20141201|ONCS|778279|0|1900960|O
I hope Punit brings his a-game and add substantial value, squeeze them.
I don't know if it was posted before, but Merkel Cell page on clinicaltrials.gov was updated.
Primary completion date 2015-06 (Anticipated)
instead of 2013-12
Interim Data on next 2 weeks and MCC presentation @ ASCO ?
Just crazy... No idea what will it take, good data next week is what everbody expects.
Today's News came as a nice surprise, removed the option of going alone.
Maybe a delayed breakout? When nobody expects it and the MM wants it
Volume slowing down... I hoped we would break that $.60 resistance.
Is it really the MMs or the shadow of the S3 that keep us down? Or both..
2M of volume in 2 hours, still can't break that 0.60s
We still not appear on Mercks headlines...
I was hoping to see Oncosec over Merck's news feed though
Added it as sticky..
Yeah, he should not be on twitter right now answering our questions. Should be working.
Hey Z, we know we are the first company in the world to use PD-1 in combination AND we are already in Phase II, hows that for a head start in the field.
Could we expect Interim results of this collaboration for ASCO 2015?!
Indeed !!
Still wonder how the market will react since there is no money involved. But like I said, we don't need to buy it at least.
I'm also surprised there is not that much action on the MB. Yesterday, they were saying that they don't expect any news this week since it's Thanksgiving over there, short trading week in the US.
Let's see how the market will react. When you think about it, we're at the same PPS level from last January.
Happy Thanksgiving !!
Not our usual 6 am news.
My fear was that Oncosec was going alone and pay for their anti-PD-1 which would have cost lots of $$$.
Wish it could appear on Merck's newsfeed.
UC San Francisco and OncoSec Medical Collaborate to Evaluate Investigational Combination of ImmunoPulse and Anti-PD-1 Treatment
http://www.businesswire.com/news/home/20141125005162/en/UC-San-Francisco-OncoSec-Medical-Collaborate-Evaluate#.VHRHWMlX9N8
Dr. Alain Algazi and Supported by OncoSec and Merck Will Evaluate Combination of KEYTRUDA® and ImmunoPulse in Metastatic Melanoma
...
This Phase II clinical trial will be conducted as a multicenter Investigator Sponsored Trial (IST), with UCSF and Dr. Alain Algazi as the sponsor. Merck will supply pembrolizumab, and OncoSec will provide electroporation devices and plasmid IL-12. Enrollment is expected to begin in Q1 2015.
0.60$ is the resistance and 0.57-0.59 is the zone just under :)
Just be patient... impatience drives people crazy, do stupid decisions and miss opportunities.
Just be happy that we didn't drop like the September presentation. We're in a much better position than September, but we're at .58 when we were at .65 back then.
$ONCS #18 most read board. Definitely have lot of eyes on this.
Work hard in silence, let your success be your noise
OncoSec Medical Inc. has entered a Sponsored Research Agreement (SRA) with the University of Washington to evaluate the immunologic mechanisms of intratumoral DNA IL-12 electroporation.
Like I said yesterday, exciting times !
You don't know much then.
OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present NEW DATA from clinical studies evaluating the Company’s ImmunoPulse immunotherapy in patients with melanoma at Melanoma Bridge 2014. The event is scheduled to take place at the Royal Continental Hotel in Naples, Italy from December 3-6, 2014.
Thx!
~20:15 we're working with a partner to be able to do so
Made me jump! Exciting times here $ONCS
Great PPS action here, still 2 weeks until the release of new data !!
December 4-5 !